Literature DB >> 28079773

Pregnancies After the Diagnosis of Mild Gestational Diabetes Mellitus and Risk of Cardiometabolic Disorders.

Michael W Varner1, Madeline Murguia Rice, Mark B Landon, Brian M Casey, Uma M Reddy, Ronald J Wapner, Dwight J Rouse, Alan T N Tita, John M Thorp, Edward K Chien, George R Saade, Alan M Peaceman, Sean C Blackwell, J Peter Vandorsten.   

Abstract

OBJECTIVE: To assess the association of subsequent pregnancy with subsequent metabolic syndrome and type II diabetes mellitus after a pregnancy complicated by mild gestational diabetes mellitus (GDM).
METHODS: We conducted a prospective observational follow-up study of women with mild GDM randomized from 2002 to 2007 to usual care or dietary intervention and glucose self-monitoring. Women were evaluated 5-10 years after the parent study. Participants were grouped according to the number of subsequent pregnancies (group A, none [reference]; group B, one; group C, two or greater). Serum triglycerides, glucose tolerance, high-density lipoprotein cholesterol, blood pressure, and waist circumference were assessed. Metabolic syndrome was diagnosed by American Heart Association and National Heart Lung and Blood Institute criteria. Multivariable regression was used to estimate adjusted relative risks (RRs) and 95% confidence intervals (CIs).
RESULTS: Of 905 eligible women from the original trial, 483 agreed to participate, 426 of whom were included in this analysis. Groups A, B, and C consisted of 212, 143, and 71 women, respectively. Of women with subsequent pregnancies, 32% (69/214) had another pregnancy complicated with GDM. No difference between groups was observed for metabolic syndrome (group A, 34%; group B, 33%; group C, 30%). Subsequent pregnancies were associated with diabetes mellitus outside of pregnancy (group A, 5.2%; group B, 10.5%, RR 2.62, 95% CI 1.16-5.91; group C, 11.3%, RR 2.83, 95% CI 1.06-7.59), and if complicated with GDM (no subsequent GDM pregnancy, RR 1.99, 95% CI 0.82-4.84; subsequent GDM pregnancy, RR 3.75, 95% CI 1.60-8.82).
CONCLUSION: In women with prior mild GDM, subsequent pregnancies did not increase the frequency of metabolic syndrome, but subsequent pregnancies with GDM increased the risk of diabetes mellitus outside of pregnancy.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28079773      PMCID: PMC5352568          DOI: 10.1097/AOG.0000000000001863

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.623


  16 in total

Review 1.  Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?

Authors:  Naveed Sattar; Ian A Greer
Journal:  BMJ       Date:  2002-07-20

Review 2.  Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy?

Authors:  Vanessa A Rodie; Dilys J Freeman; Naveed Sattar; Ian A Greer
Journal:  Atherosclerosis       Date:  2004-08       Impact factor: 5.162

3.  Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Authors:  B Isomaa; P Almgren; T Tuomi; B Forsén; K Lahti; M Nissén; M R Taskinen; L Groop
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

4.  The prevalence of the metabolic syndrome in a danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population.

Authors:  Jeannet Lauenborg; Elisabeth Mathiesen; Torben Hansen; Charlotte Glümer; Torben Jørgensen; Knut Borch-Johnsen; Peter Hornnes; Oluf Pedersen; Peter Damm
Journal:  J Clin Endocrinol Metab       Date:  2005-04-19       Impact factor: 5.958

5.  Metabolic syndrome of weight change from pre-pregnancy to 1-5 years post-partum among Chinese women with prior gestational diabetes.

Authors:  W Li; H Liu; Y Qiao; F Lv; S Zhang; L Wang; J Leng; H Liu; L Qi; J Tuomilehto; G Hu
Journal:  Diabet Med       Date:  2015-05-28       Impact factor: 4.359

Review 6.  Gestational diabetes and the incidence of type 2 diabetes: a systematic review.

Authors:  Catherine Kim; Katherine M Newton; Robert H Knopp
Journal:  Diabetes Care       Date:  2002-10       Impact factor: 19.112

Review 7.  Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis.

Authors:  Leanne Bellamy; Juan-Pablo Casas; Aroon D Hingorani; David J Williams
Journal:  BMJ       Date:  2007-11-01

Review 8.  Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses.

Authors:  Sarah D McDonald; Ann Malinowski; Qi Zhou; Salim Yusuf; Philip J Devereaux
Journal:  Am Heart J       Date:  2008-10-02       Impact factor: 4.749

9.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2011-01       Impact factor: 19.112

10.  Mild gestational diabetes mellitus and long-term child health.

Authors:  Mark B Landon; Madeline Murguia Rice; Michael W Varner; Brian M Casey; Uma M Reddy; Ronald J Wapner; Dwight J Rouse; Joseph R Biggio; John M Thorp; Edward K Chien; George Saade; Alan M Peaceman; Sean C Blackwell; J Peter VanDorsten
Journal:  Diabetes Care       Date:  2014-11-20       Impact factor: 19.112

View more
  9 in total

Review 1.  Non-communicable Diseases in Pregnant and Postpartum Women Living with HIV: Implications for Health Throughout the Life Course.

Authors:  Risa M Hoffman; Caitlin Newhouse; Brian Chu; Jeffrey S A Stringer; Judith S Currier
Journal:  Curr HIV/AIDS Rep       Date:  2021-01-05       Impact factor: 5.071

Review 2.  Risk of developing metabolic syndrome after gestational diabetes mellitus - a systematic review and meta-analysis.

Authors:  A Tranidou; T Dagklis; I Tsakiridis; A Siargkas; A Apostolopoulou; A Mamopoulos; D G Goulis; M Chourdakis
Journal:  J Endocrinol Invest       Date:  2020-11-23       Impact factor: 4.256

3.  Impact of gestational diabetes mellitus diagnosed during the third trimester on pregnancy outcomes: a case-control study.

Authors:  Ryosuke Shindo; Shigeru Aoki; Sayuri Nakanishi; Toshihiro Misumi; Etsuko Miyagi
Journal:  BMC Pregnancy Childbirth       Date:  2021-03-24       Impact factor: 3.007

Review 4.  Controversies and Advances in Gestational Diabetes-An Update in the Era of Continuous Glucose Monitoring.

Authors:  Marina P Carreiro; Anelise I Nogueira; Antonio Ribeiro-Oliveira
Journal:  J Clin Med       Date:  2018-01-25       Impact factor: 4.241

5.  Metabolic syndrome in pregnancy and risk for adverse pregnancy outcomes: A prospective cohort of nulliparous women.

Authors:  Jessica A Grieger; Tina Bianco-Miotto; Luke E Grzeskowiak; Shalem Y Leemaqz; Lucilla Poston; Lesley M McCowan; Louise C Kenny; Jenny E Myers; James J Walker; Gus A Dekker; Claire T Roberts
Journal:  PLoS Med       Date:  2018-12-04       Impact factor: 11.069

6.  Oral extracellular vesicles in early pregnancy can identify patients at risk of developing gestational diabetes mellitus.

Authors:  Lara J Monteiro; Manuel Varas-Godoy; Max Monckeberg; Ornella Realini; Marcela Hernández; Gregory Rice; Roberto Romero; José F Saavedra; Sebastián E Illanes; Alejandra Chaparro
Journal:  PLoS One       Date:  2019-06-26       Impact factor: 3.240

7.  Association of gestational diabetes mellitus and abnormal vaginal flora with adverse pregnancy outcomes.

Authors:  Xinhong Zhang; Qinping Liao; Fengying Wang; Dan Li
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

8.  Alterations in the structural characteristics of rectus abdominis muscles caused by diabetes and pregnancy: A comparative study of the rat model and women.

Authors:  Giovana Vesentini; Angélica M P Barbosa; Débora C Damasceno; Gabriela Marini; Fernanda Piculo; Selma M M Matheus; Raghavendra L S Hallur; Sthefanie K Nunes; Bruna B Catinelli; Claudia G Magalhães; Roberto Costa; Joelcio F Abbade; José E Corrente; Iracema M P Calderon; Marilza V C Rudge
Journal:  PLoS One       Date:  2020-04-03       Impact factor: 3.240

Review 9.  Contemporary clinical updates on the prevention of future cardiovascular disease in women who experience adverse pregnancy outcomes.

Authors:  Ki Park; Margo B Minissian; Janet Wei; George R Saade; Graeme N Smith
Journal:  Clin Cardiol       Date:  2020-04-17       Impact factor: 3.287

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.